We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current MORF market cap is 2.85B. The company's latest EPS is USD -3.0283 and P/E is -18.72.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 521k | 0 | 0 | 0 | 0 |
| Operating Income | -39.21M | -45.3M | -44.75M | -49.43M | -53.6M |
| Net Income | -36.14M | -39.01M | -36.21M | -40.74M | -45.29M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 16.98M | 44.95M | 19.79M | 70.81M | 521k |
| Operating Income | -46.99M | -47.18M | -95.81M | -63.4M | -178.69M |
| Net Income | -43.33M | -45M | -95.54M | -59.04M | -152.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 441.95M | 748.72M | 743.6M | 722.51M | 682.77M |
| Total Liabilities | 15.43M | 19.36M | 20.43M | 25.49M | 19.19M |
| Total Equity | 426.52M | 729.36M | 723.17M | 697.02M | 663.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 247.44M | 242.38M | 426.29M | 368.59M | 722.51M |
| Total Liabilities | 106.52M | 97.19M | 89.59M | 19.47M | 25.49M |
| Total Equity | 140.92M | 145.2M | 336.7M | 349.12M | 697.02M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.45M | -54.49M | -83.74M | -112.31M | -46.39M |
| Investing | -88.4M | -221.62M | -354.7M | -341.82M | 31.37M |
| Financing | 102.48M | 434.11M | 453.4M | 453.43M | 911k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -41.65M | -45.99M | -83.46M | -100.98M | -112.31M |
| Investing | -135.99M | 8.18M | -113.18M | -56.45M | -341.82M |
| Financing | 93.3M | 38.3M | 266.31M | 45.27M | 453.43M |
| Market Cap | 2.85B |
| Price to Earnings Ratio | -18.72 |
| Price to Sales Ratio | 5.45k |
| Price to Cash Ratio | 48.6 |
| Price to Book Ratio | 4.08 |
| Dividend Yield | - |
| Shares Outstanding | 50.22M |
| Average Volume (1 week) | 1.49M |
| Average Volume (1 Month) | 5.8M |
| 52 Week Change | 2.09% |
| 52 Week High | 62.08 |
| 52 Week Low | 19.345 |
| Spread (Intraday) | 0.05 (0.09%) |
| Company Name | Morphic Holding Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://ww.morphictx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
